{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T06:52:15Z","timestamp":1791528735058,"version":"4.3.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jdiacomp.2026.109419","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:43:16Z","timestamp":1790350996000},"page":"109419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-world effectiveness of 6-month tirzepatide therapy on body weight and composition in adults with overweight and obesity"],"prefix":"10.1016","volume":"40","author":[{"given":"Davide","family":"Brancato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Maggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Vaccaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Muratore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Pirrello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ettore","family":"Cittadini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Maria","family":"Patti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia","family":"Di Falco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Agnello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Ciaccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfredi","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2026.109419_bb0005","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity","volume":"13","author":"Rubino","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jdiacomp.2026.109419_bb0010","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1002\/oby.24358","article-title":"Projecting global trends and inequalities in adult overweight and obesity, 2023-2040: findings from the NCD-RisC Database","volume":"33","author":"Liu","year":"2025","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jdiacomp.2026.109419_bb0015","article-title":"Obesity: recent advances and future perspectives","volume":"13","author":"Jani\u0107","year":"2025","journal-title":"Biomedicines (Basel)"},{"key":"10.1016\/j.jdiacomp.2026.109419_bb0020","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/nutrit\/nux014","article-title":"Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation","volume":"75","author":"P\u00e9rez-Mart\u00ednez","year":"2017","journal-title":"Nutr Rev"},{"key":"10.1016\/j.jdiacomp.2026.109419_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2025.109045","article-title":"Obesity and its management in primary care setting","volume":"39","author":"Ibrahim","year":"2025","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jdiacomp.2026.109419_bb0030","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s13300-024-01615-5","article-title":"Modern management of cardiometabolic continuum: from overweight\/obesity to prediabetes\/type 2 diabetes mellitus. Recommendations from the Eastern and Southern Europe Diabetes and Obesity Expert Group","volume":"15","author":"Janez","year":"2024","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.jdiacomp.2026.109419_bb0035","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.2147\/DMSO.S351982","article-title":"The emerging role of dual GLP-1 and GIP receptor agonists in glycemic management and cardiovascular risk reduction","author":"Rizvi","year":"2022","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.jdiacomp.2026.109419_bb0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2026.109419_bb0045","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41366-024-01638-9","article-title":"Correlations and consistency of body composition measurement indicators and BMI: a systematic review","volume":"49","author":"Yang","year":"2025","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.jdiacomp.2026.109419_bb0050","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.2337\/dc26-S004","article-title":"4. Comprehensive medical evaluation and assessment of comorbidities: standards of care in diabetes\u20142026","volume":"49","author":"American Diabetes Association Professional Practice Committee","year":"2026","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109419_bb0055","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.clnu.2004.09.012","article-title":"Bioelectrical impedance analysis-part II: utilization in clinical practice","volume":"23","author":"Kyle","year":"2004","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jdiacomp.2026.109419_bb0060","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1517\/14656566.9.3.343","article-title":"Comparative effects of rosiglitazone and pioglitazone on fasting and postprandial low-density lipoprotein size and subclasses in patients with Type 2 diabetes","volume":"9","author":"Berneis","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jdiacomp.2026.109419_bb0065","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2026.3274","article-title":"Weight changes with tirzepatide and concomitant weight-inducing medications: post hoc analysis of randomized clinical trials","volume":"9","author":"Galindo","year":"2026","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jdiacomp.2026.109419_bb0070","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1038\/s41366-026-02088-1","article-title":"GLP-1 agonists and changes in body mass and composition in adults with overweight or obesity with or without type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"50","author":"Sawicka-Gutaj","year":"2026","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.jdiacomp.2026.109419_bb0075","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1111\/dom.16275","article-title":"Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight","volume":"27","author":"Look","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jdiacomp.2026.109419_bb0080","doi-asserted-by":"crossref","first-page":"5468","DOI":"10.1007\/s12325-025-03340-2","article-title":"Real-world weight loss observed with semaglutide and tirzepatide in patients with overweight or obesity and without type 2 diabetes (SHAPE)","volume":"42","author":"Ng","year":"2025","journal-title":"Adv Ther"},{"key":"10.1016\/j.jdiacomp.2026.109419_bb0085","article-title":"Real-world effects of incretin-based obesity medications on body composition","volume":"16","author":"Bhatti","year":"2025","journal-title":"Obes Pillars"},{"key":"10.1016\/j.jdiacomp.2026.109419_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2025.109181","article-title":"Short-term effects of low-dose tirzepatide on lipid profile, glucose homeostasis and hepatic steatosis index in adults with obesity, but without diabetes mellitus: a prospective observational study","volume":"39","author":"Angelopoulos","year":"2025","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jdiacomp.2026.109419_bb0095","doi-asserted-by":"crossref","DOI":"10.1007\/s13300-026-01868-2","article-title":"Persistence-dependent effectiveness of tirzepatide on the cardio-metabolic-kidney syndrome outcomes in obesity: real-world evidence from the United Arab Emirates","author":"Rangraze","year":"2026","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.jdiacomp.2026.109419_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2024.108812","article-title":"Can tirzepatide untie the Gordian knot of eating disorders among individuals with type 2 diabetes and obesity?","volume":"38","author":"Patoulias","year":"2024","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jdiacomp.2026.109419_bb0105","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1080\/14740338.2025.2586703","article-title":"The efficacy and safety of dual GIP\/GLP1 receptor agonists (tirzepatide) in diabetes and obesity: a systematic review and network meta-analysis","volume":"25","author":"Hoffmann","year":"2026","journal-title":"Expert Opin Drug Saf"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872726001649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872726001649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T06:46:52Z","timestamp":1791528412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872726001649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1056872726001649"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2026.109419","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world effectiveness of 6-month tirzepatide therapy on body weight and composition in adults with overweight and obesity","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2026.109419","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"109419"}}